Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists

Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists Benzoxazinones as PPARγ agonists. part 1: SAR of three aromatic regions Benzoxazinones as PPARγ Agonists. 2. SAR of the Amide Substituent and In Vivo Results in a Type 2 Diabetes Model Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia (S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl)propanoic acid compounds: Synthesis and biological evaluation of dual PPARα/γ agonists Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists Design and synthesis of oxime ethers of α-acyl-β-phenylpropanoic acids as PPAR dual agonists Design and Synthesis of Dual Peroxisome Proliferator-Activated Receptors γ and δ Agonists as Novel Euglycemic Agents with a Reduced Weight Gain Profile 5-Aryl thiazolidine-2,4-diones as selective PPARγ agonists Design and synthesis of a novel class of dual PPARγ/δ agonists